Chemours (CC) PFAS Liability Risk Appears Discounted - RBC; PT Lowered to $39
Tweet Send to a Friend
RBC Capital analyst Arun Viswanathan lowered the price target on Chemours (NYSE: CC) to $39.00 (from $43.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
